LivaNova PLC Business Combination, Consideration Transferred, Liabilities Incurred
LivaNova PLC (LIVN) reported Business Combination, Consideration Transferred, Liabilities Incurred of $16.79 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred · last filed 2023-11-01
- LivaNova PLC business combination, consideration transferred, liabilities incurred for the quarter ending 2023-09-30 was $0.00.
- LivaNova PLC business combination, consideration transferred, liabilities incurred for the quarter ending 2023-06-30 was $0.00.
- LivaNova PLC business combination, consideration transferred, liabilities incurred for the quarter ending 2023-03-31 was $16.79M.
- LivaNova PLC business combination, consideration transferred, liabilities incurred for the quarter ending 2022-12-31 was $0.00.
- LivaNova PLC business combination, consideration transferred, liabilities incurred for fiscal 2022 was $16.79M.
| Period end | Business Combination, Consideration Transferred, Liabilities Incurred 3 month | Business Combination, Consideration Transferred, Liabilities Incurred 6 month | Business Combination, Consideration Transferred, Liabilities Incurred 9 month | Business Combination, Consideration Transferred, Liabilities Incurred 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $16.79M 10-Q · filed 2023-11-01 | $16.79M derived: sum of 4 quarters · filed 2023-11-01 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $16.79M 10-Q · filed 2023-07-26 | $16.79M derived: sum of 3 quarters · filed 2023-07-26 | |
| 2023-03-31 | $16.79M 10-Q · filed 2023-05-03 | $16.79M derived: sum of 2 quarters · filed 2023-05-03 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $16.79M 10-K · filed 2023-02-27 | ||
| 2022-09-30 | $16.79M 10-Q · filed 2022-11-02 | |||
| 2016-03-31 | $4.10M 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |